Michael I Barton
6PUBLICATIONS
20CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 21, 2025
Publisher Correction: The molecular reach of antibodies crucially underpins their viral neutralisation capacity.Anna Huhn, Daniel Nissley, Daniel B Wilson
|Jan 02, 2025
The molecular reach of antibodies crucially underpins their viral neutralisation capacity.Anna Huhn, Daniel Nissley, Daniel B Wilson
|Jan 04, 2024
Using CombiCells, a platform for titration and combinatorial display of cell surface ligands, to study T-cell antigen sensitivity modulation by accessory receptors.Ashna Patel, Violaine Andre, Sofia Bustamante Eguiguren
|Mar 02, 2022
Missense variants in human ACE2 strongly affect binding to SARS-CoV-2 Spike providing a mechanism for ACE2 mediated genetic risk in Covid-19: A case study in affinity predictions of interface variants.Stuart A MacGowan, Michael I Barton, Mikhail Kutuzov
|Aug 26, 2021
Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.Michael I Barton, Stuart A MacGowan, Mikhail A Kutuzov
|Dec 10, 2019
A generic cell surface ligand system for studying cell-cell recognition.Eleanor M Denham, Michael I Barton, Susannah M Black
Pageof 1
Frequent Collaborators
5 joint publications
P Anton van der Merwe
5 joint publications
Mikhail Kutuzov
5 joint publications
Omer Dushek
2 joint publications
Juthathip Mongkolsapaya
2 joint publications
Samuel A Isaacson
2 joint publications
William James
2 joint publications
Gavin Screaton
2 joint publications
Tiong Kit Tan
2 joint publications
Stuart A MacGowan
2 joint publications
Geoffrey John Barton
